WASHINGTON (Reuters) - The U.S. Food and Drug Administration proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded ...

The FDA has decided that biosimilar medications must have unique naming features, distinguishing them from brand-name biologics in a move to improve patient safety, according to a STAT news report. 1.

Hyderabad: Prefixes and suffixes have been banned for all Ayurvedic, Siddha and Unani drugs by the department of AYUSH under the Drugs and Cosmetics Act. This notification was issued despite severe ...

The classical ayurvedic medicines being sold with prefixes and suffixes have been banned by ministry of health and family welfare on October 29. For instance, Chyawanprash is sold under brands like ...